Alexis Kelly, A. Pai, Ben S. Lertsakdadet
Nov 22, 2019
Citations
0
Influential Citations
15
Citations
Quality indicators
Journal
Lasers in Surgery and Medicine
Abstract
Oxymetazoline, an α‐1A agonist, is approved by the United States Food and Drug Administration (FDA) for treatment of persistent facial erythema associated with rosacea and induces vasoconstriction by interacting with α receptors. The objective of our study was to study the microvascular effects of oxymetazoline and pulsed dye laser (PDL).